HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus ...

When building a strong brand identity, your logo is the star of the show. It’s often the first thing customers see, recognize ...